Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis

Overview of attention for article published in Frontiers in endocrinology, January 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 10 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 5,476 followers.

RT @FrontEndocrinol: New Research: Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and typ…

21 Jan 2024

Reply Repost Favourite

RT @FrontEndocrinol: New Research: Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and typ…

20 Jan 2024

Reply Repost Favourite

Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis https://t.co/3iHnk1JSLr

20 Jan 2024

Reply Repost Favourite

New Research: Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis: Background Ultra-long-acting insulin analogs [insulin… https://t.co/yU0CaesE00 #Endo

20 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.